Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health
Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of RSV vaccines.